Visual Outcomes in Pediatric Optic Pathway Glioma after Conformal Radiation Therapy

Richard M Awdeh, Erin N. Kiehna, Richard D. Drewry, Natalie C. Kerr, Barrett G. Haik, Shengjie Wu, Xiaoping Xiong, Thomas E. Merchant

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Purpose: To assess visual outcome prospectively after conformal radiation therapy (CRT) in children with optic pathway glioma. Methods and Materials: We used CRT to treat optic pathway glioma in 20 children (median age 9.3 years) between July 1997 and January 2002. We assessed changes in visual acuity using the logarithm of the minimal angle of resolution after CRT (54 Gy) with a median follow-up of 24 months. We included in the study children who underwent chemotherapy (8 patients) or resection (9 patients) before CRT. Results: Surgery played a major role in determining baseline (pre-CRT) visual acuity (better eye: P=.0431; worse eye: P=.0032). The visual acuity in the worse eye was diminished at baseline (borderline significant) with administration of chemotherapy before CRT (P=.0726) and progression of disease prior to receiving CRT (P=.0220). In the worse eye, improvement in visual acuity was observed in patients who did not receive chemotherapy before CRT (P=.0289). Conclusions: Children with optic pathway glioma initially treated with chemotherapy prior to receiving radiation therapy have decreased visual acuity compared with those who receive primary radiation therapy. Limited surgery before radiation therapy may have a role in preserving visual acuity.

Original languageEnglish
Pages (from-to)46-51
Number of pages6
JournalInternational Journal of Radiation Oncology Biology Physics
Volume84
Issue number1
DOIs
StatePublished - Sep 1 2012
Externally publishedYes

Fingerprint

Optic Nerve Glioma
radiation therapy
Radiotherapy
visual acuity
optics
Pediatrics
Visual Acuity
chemotherapy
Drug Therapy
surgery
logarithms
progressions
preserving
Disease Progression

Keywords

  • Glioma
  • Pediatrics
  • Radiotherapy
  • Vision

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Radiation
  • Cancer Research

Cite this

Visual Outcomes in Pediatric Optic Pathway Glioma after Conformal Radiation Therapy. / Awdeh, Richard M; Kiehna, Erin N.; Drewry, Richard D.; Kerr, Natalie C.; Haik, Barrett G.; Wu, Shengjie; Xiong, Xiaoping; Merchant, Thomas E.

In: International Journal of Radiation Oncology Biology Physics, Vol. 84, No. 1, 01.09.2012, p. 46-51.

Research output: Contribution to journalArticle

Awdeh, Richard M ; Kiehna, Erin N. ; Drewry, Richard D. ; Kerr, Natalie C. ; Haik, Barrett G. ; Wu, Shengjie ; Xiong, Xiaoping ; Merchant, Thomas E. / Visual Outcomes in Pediatric Optic Pathway Glioma after Conformal Radiation Therapy. In: International Journal of Radiation Oncology Biology Physics. 2012 ; Vol. 84, No. 1. pp. 46-51.
@article{f40612a5c6e441069d6be8ab4ff3210a,
title = "Visual Outcomes in Pediatric Optic Pathway Glioma after Conformal Radiation Therapy",
abstract = "Purpose: To assess visual outcome prospectively after conformal radiation therapy (CRT) in children with optic pathway glioma. Methods and Materials: We used CRT to treat optic pathway glioma in 20 children (median age 9.3 years) between July 1997 and January 2002. We assessed changes in visual acuity using the logarithm of the minimal angle of resolution after CRT (54 Gy) with a median follow-up of 24 months. We included in the study children who underwent chemotherapy (8 patients) or resection (9 patients) before CRT. Results: Surgery played a major role in determining baseline (pre-CRT) visual acuity (better eye: P=.0431; worse eye: P=.0032). The visual acuity in the worse eye was diminished at baseline (borderline significant) with administration of chemotherapy before CRT (P=.0726) and progression of disease prior to receiving CRT (P=.0220). In the worse eye, improvement in visual acuity was observed in patients who did not receive chemotherapy before CRT (P=.0289). Conclusions: Children with optic pathway glioma initially treated with chemotherapy prior to receiving radiation therapy have decreased visual acuity compared with those who receive primary radiation therapy. Limited surgery before radiation therapy may have a role in preserving visual acuity.",
keywords = "Glioma, Pediatrics, Radiotherapy, Vision",
author = "Awdeh, {Richard M} and Kiehna, {Erin N.} and Drewry, {Richard D.} and Kerr, {Natalie C.} and Haik, {Barrett G.} and Shengjie Wu and Xiaoping Xiong and Merchant, {Thomas E.}",
year = "2012",
month = "9",
day = "1",
doi = "10.1016/j.ijrobp.2011.10.067",
language = "English",
volume = "84",
pages = "46--51",
journal = "International Journal of Radiation Oncology Biology Physics",
issn = "0360-3016",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Visual Outcomes in Pediatric Optic Pathway Glioma after Conformal Radiation Therapy

AU - Awdeh, Richard M

AU - Kiehna, Erin N.

AU - Drewry, Richard D.

AU - Kerr, Natalie C.

AU - Haik, Barrett G.

AU - Wu, Shengjie

AU - Xiong, Xiaoping

AU - Merchant, Thomas E.

PY - 2012/9/1

Y1 - 2012/9/1

N2 - Purpose: To assess visual outcome prospectively after conformal radiation therapy (CRT) in children with optic pathway glioma. Methods and Materials: We used CRT to treat optic pathway glioma in 20 children (median age 9.3 years) between July 1997 and January 2002. We assessed changes in visual acuity using the logarithm of the minimal angle of resolution after CRT (54 Gy) with a median follow-up of 24 months. We included in the study children who underwent chemotherapy (8 patients) or resection (9 patients) before CRT. Results: Surgery played a major role in determining baseline (pre-CRT) visual acuity (better eye: P=.0431; worse eye: P=.0032). The visual acuity in the worse eye was diminished at baseline (borderline significant) with administration of chemotherapy before CRT (P=.0726) and progression of disease prior to receiving CRT (P=.0220). In the worse eye, improvement in visual acuity was observed in patients who did not receive chemotherapy before CRT (P=.0289). Conclusions: Children with optic pathway glioma initially treated with chemotherapy prior to receiving radiation therapy have decreased visual acuity compared with those who receive primary radiation therapy. Limited surgery before radiation therapy may have a role in preserving visual acuity.

AB - Purpose: To assess visual outcome prospectively after conformal radiation therapy (CRT) in children with optic pathway glioma. Methods and Materials: We used CRT to treat optic pathway glioma in 20 children (median age 9.3 years) between July 1997 and January 2002. We assessed changes in visual acuity using the logarithm of the minimal angle of resolution after CRT (54 Gy) with a median follow-up of 24 months. We included in the study children who underwent chemotherapy (8 patients) or resection (9 patients) before CRT. Results: Surgery played a major role in determining baseline (pre-CRT) visual acuity (better eye: P=.0431; worse eye: P=.0032). The visual acuity in the worse eye was diminished at baseline (borderline significant) with administration of chemotherapy before CRT (P=.0726) and progression of disease prior to receiving CRT (P=.0220). In the worse eye, improvement in visual acuity was observed in patients who did not receive chemotherapy before CRT (P=.0289). Conclusions: Children with optic pathway glioma initially treated with chemotherapy prior to receiving radiation therapy have decreased visual acuity compared with those who receive primary radiation therapy. Limited surgery before radiation therapy may have a role in preserving visual acuity.

KW - Glioma

KW - Pediatrics

KW - Radiotherapy

KW - Vision

UR - http://www.scopus.com/inward/record.url?scp=84865692361&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865692361&partnerID=8YFLogxK

U2 - 10.1016/j.ijrobp.2011.10.067

DO - 10.1016/j.ijrobp.2011.10.067

M3 - Article

C2 - 22607912

AN - SCOPUS:84865692361

VL - 84

SP - 46

EP - 51

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

SN - 0360-3016

IS - 1

ER -